Truitt Kenneth 4
4 · Aquestive Therapeutics, Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
Truitt Kenneth
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2022-09-06+100,000→ 100,000 totalExercise: $1.25Exp: 2032-09-06→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Granted as an inducement equity award under the Aquestive Therapeutics, Inc. 2022 Inducement Equity Incentive Plan in accordance with Nasdaq Listing Rule 5636(c)(4). The options will vest annually 25% on the first and second anniversaries of the Grant Date and 50% on the third anniversary of the Grant Date, subject to Dr. Truitt's continued employment through the applicable vesting date.